PLx Pharma Inc. announced the appointment of Tom Long as Vice President, Manufacturing & Technical Operations, effective immediately. Mr. Long will oversee ongoing manufacturing efforts for Aspertec. Steven Valentino, will join PLx as Vice President, Trade Sales, effective October 1, 2017. He will be responsible for building retail trade accounts, developing retailer and wholesaler relationships for PLx and securing distribution and merchandising support. Concurrently Gary Mossman, Chief Operating Officer, will transition into a senior advisory role. Mr. Mossman will continue to actively advise the company to ensure that appropriate manufacturing capacity is available for Aspertec through launch. Most recently, Mr. Long has independently consulted in building manufacturing and technical operations for several manufacturers large and small. Mr. Valentino is a highly-credentialed executive with over 25 years of experience in the OTC and consumer healthcare space. His experience includes Rx to OTC switches, brand management, trade sales and operations and customer development across Drug, Mass Food and Specialty. Most recently, Steven Valentino served as Vice President of Crossmark Drug, a division of Crossmark, where he was responsible for drug wholesale, dollar and retail merchandising for brand and private label products.